Popular diabetes drug does not improve survival rates after cancer
The study, published in the journal Diabetes Care, failed to show an improved survival rate in older breast cancer patients with diabetes taking the drug metformin, a first-line treatment for diabetes. However, the authors caution further research is necessary to validate the study’s findings. "Metformin is a drug commonly used by diabetic patients to control the amount of glucose in their blood," said the study’s lead author Dr. Iliana Lega, a research fellow at Women’s College Research Institute…